Why Not Make RMPs for Existing Products as Differentiation Strategy?

Now that one year has passed since the introduction of risk management plans (RMPs) in Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) has recently been releasing RMPs at an increasingly faster pace. RMPs for a total of 16 active...read more